Actively Recruiting
Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
Led by The University of Texas Health Science Center, Houston · Updated on 2025-01-09
1000
Participants Needed
2
Research Sites
1317 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.
CONDITIONS
Official Title
Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with congenital or acquired bleeding or clotting disorders who have provided informed consent and/or assent
You will not qualify if you...
- Poor venous access
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
The Univerisity of Texas Health Science Center at Houston
Houston, Texas, United States, 77030
Actively Recruiting
2
UT Physicians Women's Center-Texas Medical Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
K
Katherine Addy, RN, BSN, MPH
CONTACT
D
Daisy Garcia, RN, BSN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here